NCT05427630: An ongoing trial by University of California, San Diego
This trial is ongoing. It must report results 2 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05427630 |
|---|---|
| Title | Inhaled Cannabis Versus Placebo for the Acute Treatment of Migraine: a Pilot, Randomized, Double-blind, Placebo-controlled, Crossover, Dose-ranging Trial |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Feb. 15, 2023 |
| Completion date | June 1, 2024 |
| Required reporting date | June 1, 2025, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | None |